Bariatric Surgery, Arterial Stiffness and Target Organ Damage Study (BASTOD)
BASTOD
Longitudinal Assessment of the Effect of Bariatric Surgery on Arterial Function and Blood Pressure Target Organs Damage
2 other identifiers
observational
90
1 country
1
Brief Summary
Introduction: Obesity is a major public health problem, associated with many morbidities, including metabolic and cardiovascular disease (CVD). High blood pressure (hypertension) is the most common comorbidity and one of the major risk factors for CVD and kidney failure. It has been described an almost linear relationship between body mass index (BMI) and the level of blood pressure (BP), but the mechanisms underlying this relationship are complex and incompletely understood : activation of renin-angiotensin-aldosterone and sympathetic nervous systems, alterations in systemic hemodynamics and arterial parameters; a significant correlation between overall and / or visceral obesity and arterial stiffness assessed by carotid-femoral pulse wave velocity (PWV) has been observed. By its effectiveness in terms of magnitude and sustainability of weight loss, bariatric surgery is becoming increasingly important in the management of obesity and the prevention of its comorbidities. It reduces all-cause as well as CV mortality. Bariatric surgery allows a resolution of the metabolic syndrome (in 2 out of 3 patients) and diabetes (in 5 out of 6 patients), but its effect on blood pressure remains inconstant and transient. The reasons for this limitation and the detailed effects of bariatric surgery on hemodynamics and arterial parameters have been poorly studied. Of note, a reduction in left ventricular hypertrophy, an improvement in diastolic dysfunction and aortic distensibility assessed by ultrasound or MRI have been observed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 17, 2011
CompletedStudy Start
First participant enrolled
December 1, 2011
CompletedFirst Posted
Study publicly available on registry
December 16, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedDecember 1, 2016
November 1, 2016
3.1 years
November 17, 2011
November 30, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Arterial stiffness
Change in Arterial stiffness at 6 and 12 months(determined non-invasively by measurement of PWV, central pressure and reflection wavelength)
6 and 12 month (plus or minus 30 days) after bariatric surgery
Secondary Outcomes (1)
Changes at 6 and 12 months
at 6 and 12 months
Interventions
Bariatric surgery
Eligibility Criteria
obese patient candidate for bariatric surgery
You may qualify if:
- BMI \> 40 kg/m2 or BMI 35-40 with major comorbidities
- Age between 18-60 years
- Obesity evolving for more than 5 years
- Failure of medical treatment
- Elimination of hormonal causes
You may not qualify if:
- Uncontrolled hypertension (SBP \> 160 mmHg and DBP\> 100 mmHg).
- History of cardiovascular disease or signs of clinical atheroma: stroke, myocardial infarction and coronary heart disease (angina), peripheral arterial disease (no pulse, claudication), aortic aneurysm (anterior abdominal palpation or imaging ), carotid bruit
- Plasma creatinine \> 130 micromol/L and/or proteinuria \> 300 mg/24 h and/or dipstick hematuria.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital
Montpellier, 34925, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Matthieu Sardinoux, M.D.
UH Montpellier
Study Design
- Study Type
- observational
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2011
First Posted
December 16, 2011
Study Start
December 1, 2011
Primary Completion
January 1, 2015
Study Completion
March 1, 2016
Last Updated
December 1, 2016
Record last verified: 2016-11